Libre Sense News Today

PRINCIPAL DESIGN ENGINEER, DEVELOPMENT ENGINEERING job in Oxfordshire with Abbott. Apply Today.

Expansions in access by the Centers of Medicare and Medicaid Services could bring the latest advances in continuous glucose monitoring into the hands of millions with diabetes, which could provide significant, population-level impact and bring the field a step closer to equitable diabetes management.

/PRNewswire/ -- Supersapiens, the worlds only real-time energy management system, designed for athletes to unlock better performance and recovery, adds...

/PRNewswire/ -- Supersapiens, powered by Abbotts Libre Sense Glucose Sport Biosensor, announced the appointment of five members to its board of directors: Pam...

The NN Running Team, which has world marathon record holder Eliud Kipchoge, has extended its partnership with Abbot, a global health care company.

Abbott Labs Board Chairman/CEO Robert Ford gives the first keynote address by a healthcare company representative in CES history.

Strength in Diabetes Care and Diagnostics businesses is driving Abbott's (ABT) top line.

Author Bio Adria Cimino grew up with her nose in a book and a love of storytelling. By a twist of fate, she started her career writing about biotech in Boston and discovered that each company is the source of many fascinating stories. Prior to joining The Fool as a contract writer focused on healthcare and consumer goods, Adria covered the stock market for Bloomberg News in Paris. When she’s not analyzing companies, she can be found writing fiction or trying to speak F...

Share this article Share this article ATLANTA, April 27, 2021 /PRNewswire/ -- Supersapiens announces a $13.5 million capital raise led by MICA Ventures AG. The new energy management ecosystem, powered by Abbotts Libre Sense Glucose Sport Biosensor, has secured the largest investment in the sports continuous glucose monitoring (CGM) space, garnering investment from preeminent fitness and performance brands including the founder of Zwift and Wahoo. Supersapiens Closes $13.5 Million in Early-Stag...

Share this article Share this article ABBOTT PARK, Ill., April 20, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2021. First-quarter sales of $10.5 billion increased 35.3 percent on a reported basis and 32.9 percent on an organic basis, which excludes the impact of foreign exchange. First-quarter GAAP diluted EPS was $1.00 and adjusted diluted EPS, which excludes specified items, was $1.32, reflecting 103.1 percent growth vers...